Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: Description of two unrelated cases from Brazil

Texto completo
Autor(es):
Mostrar menos -
Jesus, Adriana A. [1] ; Osman, Mazen [2] ; Silva, Clovis A. [1] ; Kim, Peter W. [3] ; Pham, Tuyet-Hang [4] ; Gadina, Massimo [4] ; Yang, Barbara [4] ; Bertola, Debora R. [1] ; Carneiro-Sampaio, Magda [1] ; Ferguson, Polly J. [5] ; Renshaw, Blair R. [6] ; Schooley, Ken [6] ; Brown, Michael [6] ; Al-Dosari, Asma [2] ; Al-Alami, Jamil [2] ; Sims, John E. [6] ; Goldbach-Mansky, Raphaela [4] ; El-Shanti, Hatem [2, 5]
Número total de Autores: 18
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Sao Paulo - Brazil
[2] Shafallah Med Genet Ctr, Doha - Qatar
[3] NIAMSD, NIH, Bethesda, MD 20892 - USA
[4] Tuyet-Hang Pham, NIAMSD, NIH, Bethesda, MD 20892 - USA
[5] Univ Iowa, Carver Coll Med, Iowa City, IA - USA
[6] Amgen Inc, Seattle, WA - USA
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: ARTHRITIS AND RHEUMATISM; v. 63, n. 12, p. 4007-4017, DEC 2011.
Citações Web of Science: 42
Resumo

Objective Monogenic autoinflammatory diseases are disorders of Mendelian inheritance that are characterized by mutations in genes that regulate innate immunity and whose typical features are systemic inflammation without high-titer autoantibodies or antigen-specific T cells. Skin and bone inflammation in the newborn period have been described in 3 of these autoinflammatory disorders: neonatal-onset multisystem inflammatory disease, Majeed syndrome, and deficiency of interleukin-1 (IL-1) receptor antagonist (DIRA) syndrome. This study was undertaken to present the characteristics of the DIRA syndrome in 2 cases from Brazil, and describe a novel mutation in IL1RN. Methods. Two unrelated Brazilian patients were evaluated for the clinical signs and symptoms of these 3 disorders, and peripheral blood samples were assessed for mutations in NLRP3, LPIN2, and IL1RN by DNA resequencing analysis. A mutation in IL1RN that encodes a mutant protein was identified, and the expression and function of this mutant protein were compared to those of the wild-type protein. Results. Both patients presented with pustular dermatitis resembling generalized pustular psoriasis, recurrent multifocal aseptic osteomyelitis, and elevation in the levels of acute-phase reactants, all of which are features most consistent with the DIRA syndrome. Chronic lung disease was observed in 1 of the patients, and jugular venous thrombosis was observed in the other patient. Both patients showed a partial response to corticosteroid therapy, and 1 patient experienced an initial improvement of dermatitis with the use of acitretin. Both patients were homozygous for a novel 15-bp (in-frame) deletion on the IL1RN gene. The mutated protein expressed in vitro had no affinity with the IL-1 receptor, and stimulation of the patients' cells with recombinant human IL-1 alpha or IL-1 alpha led to oversecretion of proinflammatory cytokines, similar to the findings obtained in previously reported patients. Conclusion. The presence of the same homozygous novel mutation in IL1RN in 2 unrelated Brazilian patients suggests that this genetic variant may be a founder mutation that has been introduced in the Brazilian population. (AU)

Processo FAPESP: 02/05880-4 - Imunodeficiências primárias em pacientes pediátricos de risco: relações entre manifestações clínicas e alterações genéticas
Beneficiário:Magda Maria Sales Carneiro-Sampaio
Modalidade de apoio: Auxílio à Pesquisa - Temático